Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

Recruiting N/A Interventional Study
Excessive Hairiness Vascular Lesion Pigmented Lesions Acne Vulgaris
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
85 (estimated)
Sponsor
Eurofeedback · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, its favorable cost and versatility in contrast to many singlespectrum lasers, has led to its rapid proliferation and use in a number of different clinical settings. As described in the literature, ANTHÉLIA medical device is intended to treat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult men or women * Excessive Hairiness: * Patient with unwanted hair on the body (legs, arms, bikini line, or axilla) * Patient over 18 years. * Patients with Fitzpatrick skin types from I to V. * Women were required to be post-menopausal, surgically sterilized, or under a m…
Contacts

Laurent Zawadil

01 60 86 31 10

s.qualite@eurofeedback.com

CONTACT